The Society for Immunotherapy of Cancer (SITC) will host a summit on The Future of Neoadjuvant Clinical Trial Design on Thursday, June 26, 2025, from 11 a.m-3 p.m. EDT. The virtual summit is a free, public event that features invited speakers, expert panel discussions, and attendee question and answer periods. The multi-stakeholder virtual summit will feature expert faculty presenters at the forefront of perioperative immunotherapy and clinical trial design.
The SITC Summit on The Future of Neoadjuvant Clinical Trial Design will focus on two major topics: assessing the contribution of each treatment phase toward clinical efficacy and endpoints in clinical trials of neoadjuvant or perioperative immunotherapies for early-stage resectable cancers. These topics will be addressed through reviewing data and insights from recent clinical trials of immunotherapy in the neoadjuvant/perioperative setting including I-SPY, NeoCOAST-2, and others. The program will conclude with globally renowned faculty sharing state-of-the-art updates for a wide range of cancer types that have made unique contributions to understanding the biology and clinical development of neoadjuvant and perioperative therapies.